1 Nuclear Medicine & Radiopharmaceuticals Market Overview |
1.1 Product Overview and Scope of Nuclear Medicine & Radiopharmaceuticals |
1.2 Nuclear Medicine & Radiopharmaceuticals Segment by Type |
| 1.2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate Comparison by Type (2021-2026) |
| 1.2.2 Diagnostic Radioisotopes |
| 1.2.3 Therapeutic Radioisotopes |
1.3 Nuclear Medicine & Radiopharmaceuticals Segment by Application |
| 1.3.1 Nuclear Medicine & Radiopharmaceuticals Sales Comparison by Application: 2020 VS 2026 |
| 1.3.2 Oncology |
| 1.3.3 Cardiology |
| 1.3.4 Other |
1.4 Global Nuclear Medicine & Radiopharmaceuticals Market Size Estimates and Forecasts |
| 1.4.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue 2015-2026 |
| 1.4.2 Global Nuclear Medicine & Radiopharmaceuticals Sales 2015-2026 |
| 1.4.3 Nuclear Medicine & Radiopharmaceuticals Market Size by Region: 2020 Versus 2026 |
2 Global Nuclear Medicine & Radiopharmaceuticals Market Competition by Manufacturers |
2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Manufacturers (2015-2020) |
2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Share by Manufacturers (2015-2020) |
2.3 Global Nuclear Medicine & Radiopharmaceuticals Average Price by Manufacturers (2015-2020) |
2.4 Manufacturers Nuclear Medicine & Radiopharmaceuticals Manufacturing Sites, Area Served, Product Type |
2.5 Nuclear Medicine & Radiopharmaceuticals Market Competitive Situation and Trends |
| 2.5.1 Nuclear Medicine & Radiopharmaceuticals Market Concentration Rate |
| 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue |
| 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) |
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans |
2.7 Primary Interviews with Key Nuclear Medicine & Radiopharmaceuticals Players (Opinion Leaders) |
3 Nuclear Medicine & Radiopharmaceuticals Retrospective Market Scenario by Region |
3.1 Global Nuclear Medicine & Radiopharmaceuticals Retrospective Market Scenario in Sales by Region: 2015-2020 |
3.2 Global Nuclear Medicine & Radiopharmaceuticals Retrospective Market Scenario in Revenue by Region: 2015-2020 |
3.3 North America Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country |
| 3.3.1 North America Nuclear Medicine & Radiopharmaceuticals Sales by Country |
| 3.3.2 North America Nuclear Medicine & Radiopharmaceuticals Sales by Country |
| 3.3.3 U.S. |
| 3.3.4 Canada |
3.4 Europe Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country |
| 3.4.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country |
| 3.4.2 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country |
| 3.4.3 Germany |
| 3.4.4 France |
| 3.4.5 U.K. |
| 3.4.6 Italy |
| 3.4.7 Russia |
3.5 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Region |
| 3.5.1 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Region |
| 3.5.2 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Region |
| 3.5.3 China |
| 3.5.4 Japan |
| 3.5.5 South Korea |
| 轉~自：http://www.5269660.cn/1/31/Global-Nuclear-Medicine-Radiopharmaceuticals-Market-Research-and-Trends-Analysis-Report-.html |
| 3.5.6 India |
| 3.5.7 Australia |
| 3.5.8 Taiwan, China |
| 3.5.9 Indonesia |
| 3.5.10 Thailand |
| 3.5.11 Malaysia |
| 3.5.12 Philippines |
| 3.5.13 Vietnam |
3.6 Latin America Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country |
| 3.6.1 Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Country |
| 3.6.2 Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Country |
| 3.6.3 Mexico |
| 3.6.3 Brazil |
| 3.6.3 Argentina |
3.7 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Facts & Figures by Country |
| 3.7.1 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country |
| 3.7.2 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country |
| 3.7.3 Turkey |
| 3.7.4 Saudi Arabia |
| 3.7.5 U.A.E |
4 Global Nuclear Medicine & Radiopharmaceuticals Historic Market Analysis by Type |
4.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2015-2020) |
4.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2015-2020) |
4.3 Global Nuclear Medicine & Radiopharmaceuticals Price Market Share by Type (2015-2020) |
4.4 Global Nuclear Medicine & Radiopharmaceuticals Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End |
5 Global Nuclear Medicine & Radiopharmaceuticals Historic Market Analysis by Application |
5.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2015-2020) |
5.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application (2015-2020) |
5.3 Global Nuclear Medicine & Radiopharmaceuticals Price by Application (2015-2020) |
6 Company Profiles and Key Figures in Nuclear Medicine & Radiopharmaceuticals Business |
6.1 Company 1 |
| 6.1.1 Corporation Information |
| 6.1.2 Company 1 Description, Business Overview and Total Revenue |
| 6.1.3 Company 1 Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020) |
| 6.1.4 Company 1 Products Offered |
| 6.1.5 Company 1 Recent Development |
6.2 Company 2 |
| 6.2.1 Company 2 Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served |
| 6.2.2 Company 2 Description, Business Overview and Total Revenue |
| 6.2.3 Company 2 Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020) |
| 6.2.4 Company 2 Products Offered |
| 6.2.5 Company 2 Recent Development |
6.3 Company 3 |
| 6.3.1 Company 3 Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served |
| 6.3.2 Company 3 Description, Business Overview and Total Revenue |
| 6.3.3 Company 3 Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020) |
| 6.3.4 Company 3 Products Offered |
| 6.3.5 Company 3 Recent Development |
6.4 Company 4 |
| 6.4.1 Company 4 Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served |
| 6.4.2 Company 4 Description, Business Overview and Total Revenue |
| 6.4.3 Company 4 Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020) |
| 6.4.4 Company 4 Products Offered |
| 6.4.5 Company 4 Recent Development |
6.5 Company 5 |
| 6.5.1 Company 5 Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served |
| 6.5.2 Company 5 Description, Business Overview and Total Revenue |
| 6.5.3 Company 5 Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020) |
| 6.5.4 Company 5 Products Offered |
| 6.5.5 Company 5 Recent Development |
6.6 Company 6 |
| 6.6.1 Company 6 Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served |
| 6.6.2 Company 6 Description, Business Overview and Total Revenue |
| 6.6.3 Company 6 Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020) |
| 6.6.4 Company 6 Products Offered |
| 6.6.5 Company 6 Recent Development |
6.7 Company 7 |
| 6.6.1 Company 7 Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served |
| 6.6.2 Company 7 Description, Business Overview and Total Revenue |
| 6.6.3 Company 7 Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020) |
| 6.4.4 Company 7 Products Offered |
| 6.7.5 Company 7 Recent Development |
6.8 Company 8 |
| 6.8.1 Company 8 Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served |
| 6.8.2 Company 8 Description, Business Overview and Total Revenue |
| 6.8.3 Company 8 Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020) |
| 6.8.4 Company 8 Products Offered |
| 6.8.5 Company 8 Recent Development |
6.9 Company 9 |
| 6.9.1 Company 9 Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served |
| 6.9.2 Company 9 Description, Business Overview and Total Revenue |
| 6.9.3 Company 9 Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020) |
| 6.9.4 Company 9 Products Offered |
| 6.9.5 Company 9 Recent Development |
6.10 Company 10 |
| 6.10.1 Company 10 Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served |
| 6.10.2 Company 10 Description, Business Overview and Total Revenue |
| 6.10.3 Company 10 Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020) |
| 6.10.4 Company 10 Products Offered |
| 6.10.5 Company 10 Recent Development |
6.11 Company 11 |
| 6.11.1 Company 11 Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served |
| 6.11.2 Company 11 Nuclear Medicine & Radiopharmaceuticals Description, Business Overview and Total Revenue |
| 6.11.3 Company 11 Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020) |
| 全球核醫學和放射性藥物市場研究及發展趨勢分析報告二〇二〇年至2026年 |
| 6.11.4 Company 11 Products Offered |
| 6.11.5 Company 11 Recent Development |
6.12 Company 12 |
| 6.12.1 Company 12 Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served |
| 6.12.2 Company 12 Nuclear Medicine & Radiopharmaceuticals Description, Business Overview and Total Revenue |
| 6.12.3 Company 12 Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020) |
| 6.12.4 Company 12 Products Offered |
| 6.12.5 Company 12 Recent Development |
6.13 Company 13 |
| 6.13.1 Company 13 Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served |
| 6.13.2 Company 13 Nuclear Medicine & Radiopharmaceuticals Description, Business Overview and Total Revenue |
| 6.13.3 Company 13 Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020) |
| 6.13.4 Company 13 Products Offered |
| 6.13.5 Company 13 Recent Development |
6.14 Company 14 |
| 6.14.1 Company 14 Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served |
| 6.14.2 Company 14 Nuclear Medicine & Radiopharmaceuticals Description, Business Overview and Total Revenue |
| 6.14.3 Company 14 Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020) |
| 6.14.4 Company 14 Products Offered |
| 6.14.5 Company 14 Recent Development |
6.15 Company 15 |
| 6.15.1 Company 15 Nuclear Medicine & Radiopharmaceuticals Production Sites and Area Served |
| 6.15.2 Company 15 Nuclear Medicine & Radiopharmaceuticals Description, Business Overview and Total Revenue |
| 6.15.3 Company 15 Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020) |
| 6.15.4 Company 15 Products Offered |
| 6.15.5 Company 15 Recent Development |
7 Nuclear Medicine & Radiopharmaceuticals Manufacturing Cost Analysis |
7.1 Nuclear Medicine & Radiopharmaceuticals Key Raw Materials Analysis |
| 7.1.1 Key Raw Materials |
| 7.1.2 Key Raw Materials Price Trend |
| 7.1.3 Key Suppliers of Raw Materials |
7.2 Proportion of Manufacturing Cost Structure |
7.3 Manufacturing Process Analysis of Nuclear Medicine & Radiopharmaceuticals |
7.4 Nuclear Medicine & Radiopharmaceuticals Industrial Chain Analysis |
8 Marketing Channel, Distributors and Customers |
8.1 Marketing Channel |
8.2 Nuclear Medicine & Radiopharmaceuticals Distributors List |
8.3 Nuclear Medicine & Radiopharmaceuticals Customers |
9 Market Dynamics |
9.1 Market Trends |
9.2 Opportunities and Drivers |
9.3 Challenges |
9.4 Porter's Five Forces Analysis |
10 Global Market Forecast |
10.1 Global Nuclear Medicine & Radiopharmaceuticals Market Estimates and Projections by Type |
| 10.1.1 Global Forecasted Sales of Nuclear Medicine & Radiopharmaceuticals by Type (2021-2026) |
| 10.1.2 Global Forecasted Revenue of Nuclear Medicine & Radiopharmaceuticals by Type (2021-2026) |
10.2 Nuclear Medicine & Radiopharmaceuticals Market Estimates and Projections by Application |
| 10.2.1 Global Forecasted Sales of Nuclear Medicine & Radiopharmaceuticals by Application (2021-2026) |
| 10.2.2 Global Forecasted Revenue of Nuclear Medicine & Radiopharmaceuticals by Application (2021-2026) |
10.3 Nuclear Medicine & Radiopharmaceuticals Market Estimates and Projections by Region |
| 10.3.1 Global Forecasted Sales of Nuclear Medicine & Radiopharmaceuticals by Region (2021-2026) |
| 10.3.2 Global Forecasted Revenue of Nuclear Medicine & Radiopharmaceuticals by Region (2021-2026) |
10.4 North America Nuclear Medicine & Radiopharmaceuticals Estimates and Projections (2021-2026) |
10.5 Europe Nuclear Medicine & Radiopharmaceuticals Estimates and Projections (2021-2026) |
10.6 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Estimates and Projections (2021-2026) |
10.7 Latin America Nuclear Medicine & Radiopharmaceuticals Estimates and Projections (2021-2026) |
10.8 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Estimates and Projections (2021-2026) |
11 Research Finding and Conclusion |
12 Methodology and Data Source |
12.1 Methodology/Research Approach |
| 12.1.1 Research Programs/Design |
| 12.1.2 Market Size Estimation |
| 12.1.3 Market Breakdown and Data Triangulation |
12.2 Data Source |
| 12.2.1 Secondary Sources |
| 12.2.2 Primary Sources |
12.3 Author List |
12.4 Disclaimer |
| List of Tables |
| Table 1. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Dose) Growth Rate Comparison by Type (2015-2026) |
| Table 2. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Dose) Comparison by Application: 2020 VS 2026 |
| Table 3. Global Nuclear Medicine & Radiopharmaceuticals Market Size by Type (K Dose) (US$ Million) (2020 VS 2026) |
| Table 4. Global Key Nuclear Medicine & Radiopharmaceuticals Manufacturers Covered in This Study |
| Table 5. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Dose) by Manufacturers (2015-2020) |
| Table 6. Global Nuclear Medicine & Radiopharmaceuticals Sales Share by Manufacturers (2015-2020) |
| Table 7. Global Nuclear Medicine & Radiopharmaceuticals Revenue (Million USD) by Manufacturers (2015-2020) |
| Table 8. Global Nuclear Medicine & Radiopharmaceuticals Revenue Share by Manufacturers (2015-2020) |
| Table 9. Global Market Nuclear Medicine & Radiopharmaceuticals Average Price (USD/Dose) of Key Manufacturers (2015-2020) |
| Table 10. Manufacturers Nuclear Medicine & Radiopharmaceuticals Sales Sites and Area Served |
| Table 11. Manufacturers Nuclear Medicine & Radiopharmaceuticals Product Types |
| Table 12. Global Nuclear Medicine & Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI) |
| Table 13. Global Nuclear Medicine & Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Medicine & Radiopharmaceuticals as of 2019) |
| Table cturers Mergers & Acquisitions, Expansion Plans |
| Table 15. Main Points Interviewed from Key Nuclear Medicine & Radiopharmaceuticals Players |
| Table 16. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Dose) by Region (2015-2020) |
| Table 17. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2015-2020) |
| Table 18. Global Nuclear Medicine & Radiopharmaceuticals Revenue (Million US$) by Region (2015-2020) |
| Table 19. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2015-2020) |
| Table 20. North America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2015-2020) (K Dose) |
| Table 21. North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2015-2020) |
| Table 22. North America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million) |
| Table 23. North America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2015-2020) |
| Table 24. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2015-2020) (K Dose) |
| Table 25. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2015-2020) |
| 全球核醫學和放射性藥物市場研究及發展趨勢分析報告二〇二〇年至2026年 |
| Table 26. Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million) |
| Table 27. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2015-2020) |
| Table 28. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Region (2015-2020) (K Dose) |
| Table 29. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2015-2020) |
| Table 30. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2015-2020) (US$ Million) |
| Table 31. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2015-2020) |
| Table 32. Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2015-2020) (K Dose) |
| Table 33. Latin America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2015-2020) |
| Table 34. Latin America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million) |
| Table 35. Latin America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2015-2020) |
| Table 36. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2015-2020) (K Dose) |
| Table 37. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2015-2020) |
| Table 38. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million) |
| Table 39. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2015-2020) |
| Table 40. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Dose) by Type (2015-2020) |
| Table 41. Global Nuclear Medicine & Radiopharmaceuticals Sales Share by Type (2015-2020) |
| Table 42. Global Nuclear Medicine & Radiopharmaceuticals Revenue (Million US$) by Type (2015-2020) |
| Table 43. Global Nuclear Medicine & Radiopharmaceuticals Revenue Share by Type (2015-2020) |
| Table 44. Global Nuclear Medicine & Radiopharmaceuticals Price (USD/Dose) by Type (2015-2020) |
| Table 45. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Dose) by Application (2015-2020) |
| Table 46. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2015-2020) |
| Table 47. Global Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate by Application (2015-2020) |
| Table 48. Company 1 Nuclear Medicine & Radiopharmaceuticals Corporation Information |
| Table 49. Company 1 Description and Business Overview |
| Table 50. Company 1 Nuclear Medicine & Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) |
| Table 51. Company 1 Main Product |
| Table 52. Company 1 Recent Development |
| Table 53. Company 2 Nuclear Medicine & Radiopharmaceuticals Corporation Information |
| Table 54. Company 2 Corporation Information |
| Table 55. Company 2 Nuclear Medicine & Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) |
| Table 56. Company 2 Main Product |
| Table 57. Company 2 Recent Development |
| Table 58. Company 3 Nuclear Medicine & Radiopharmaceuticals Corporation Information |
| Table 59. Company 3 Corporation Information |
| Table 60. Company 3 Nuclear Medicine & Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) |
| Table 61. Company 3 Main Product |
| Table 62. Company 3 Recent Development |
| Table 63. Company 4 Nuclear Medicine & Radiopharmaceuticals Corporation Information |
| Table 64. Company 4 Corporation Information |
| Table 65. Company 4 Nuclear Medicine & Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) |
| Table 66. Company 4 Main Product |
| Table 67. Company 4 Recent Development |
| Table 68. Company 5 Nuclear Medicine & Radiopharmaceuticals Corporation Information |
| Table 69. Company 5 Corporation Information |
| Table 70. Company 5 Nuclear Medicine & Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) |
| Table 71. Company 5 Main Product |
| Table 72. Company 5 Recent Development |
| Table 73. Company 6 Nuclear Medicine & Radiopharmaceuticals Corporation Information |
| Table 74. Company 6 Corporation Information |
| Table 75. Company 6 Nuclear Medicine & Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) |
| Table 76. Company 6 Main Product |
| Table 77. Company 6 Recent Development |
| Table 78. Company 7 Nuclear Medicine & Radiopharmaceuticals Corporation Information |
| Table 79. Company 7 Corporation Information |
| Table 80. Company 7 Nuclear Medicine & Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) |
| Table 81. Company 7 Main Product |
| Table 82. Company 7 Recent Development |
| Table 83. Company 8 Nuclear Medicine & Radiopharmaceuticals Corporation Information |
| Table 84. Company 8 Corporation Information |
| Table 85. Company 8 Nuclear Medicine & Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) |
| Table 86. Company 8 Main Product |
| Table 87. Company 8 Recent Development |
| Table 88. Company 9 Nuclear Medicine & Radiopharmaceuticals Corporation Information |
| Table 89. Company 9 Corporation Information |
| Table 90. Company 9 Nuclear Medicine & Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) |
| Table 91. Company 9 Main Product |
| Table 92. Company 9 Recent Development |
| Table 93. Company 10 Nuclear Medicine & Radiopharmaceuticals Corporation Information |
| Table 94. Company 10 Corporation Information |
| Table 95. Company 10 Nuclear Medicine & Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) |
| Table 96. Company 10 Main Product |
| Table 97. Company 10 Recent Development |
| Table 98. Company 11 Nuclear Medicine & Radiopharmaceuticals Corporation Information |
| Table 99. Company 11 Corporation Information |
| Table 100. Company 11 Nuclear Medicine & Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) |
| Table 101. Company 11 Main Product |
| Table 102. Company 11 Recent Development |
| Table 103. Company 12 Nuclear Medicine & Radiopharmaceuticals Corporation Information |
| Table 104. Company 12 Corporation Information |
| Table 105. Company 12 Nuclear Medicine & Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) |
| Table 106. Company 12 Main Product |
| Table 107. Company 12 Recent Development |
| Table 108. Company 13 Nuclear Medicine & Radiopharmaceuticals Corporation Information |
| Table 109. Company 13 Corporation Information |
| Table 110. Company 13 Nuclear Medicine & Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) |
| Table 111. Company 13 Main Product |
| Table 112. Company 13 Recent Development |
| Table 113. Company 14 Nuclear Medicine & Radiopharmaceuticals Corporation Information |
| Table 114. Company 14 Corporation Information |
| Table 115. Company 14 Nuclear Medicine & Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) |
| Table 116. Company 14 Main Product |
| Table 117. Company 14 Recent Development |
| Table 118. Company 15 Nuclear Medicine & Radiopharmaceuticals Corporation Information |
| Table 119. Company 15 Corporation Information |
| Table 120. Company 15 Nuclear Medicine & Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) |
| quánqiú hé yīxué hé fàngshèxìng yàowù shìchǎng yánjiū jí fāzhǎn qūshì fēnxī bàogào èr líng èr líng nián zhì 2026 nián |
| Table 121. Company 15 Main Product |
| Table 122. Company 15 Recent Development |
| Table 123. Sales Base and Market Concentration Rate of Raw Material |
| Table 124. Key Suppliers of Raw Materials |
| Table 125. Nuclear Medicine & Radiopharmaceuticals Distributors List |
| Table 126. Nuclear Medicine & Radiopharmaceuticals Customers List |
| Table 127. Market Key Trends |
| Table 128. Key Opportunities and Drivers: Impact Analysis (2021-2026) |
| Table 129. Key Challenges |
| Table 130. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Dose) Forecast by Type (2021-2026) |
| Table 131. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share Forecast by Type (2021-2026) |
| Table 132. Global Nuclear Medicine & Radiopharmaceuticals Revenue (Million US$) Forecast by Type (2021-2026) |
| Table 133. Global Nuclear Medicine & Radiopharmaceuticals Revenue (Million US$) Market Share Forecast by Type (2021-2026) |
| Table 134. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Dose) Forecast by Application (2021-2026) |
| Table 135. Global Nuclear Medicine & Radiopharmaceuticals Revenue (Million US$) Forecast by Application (2021-2026) |
| Table 136. Global Nuclear Medicine & Radiopharmaceuticals Sales (K Dose) Forecast by Region (2021-2026) |
| Table 137. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share Forecast by Region (2021-2026) |
| Table 138. Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by Region (2021-2026) (US$ Million) |
| Table 139. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share Forecast by Region (2021-2026) |
| Table 140. Research Programs/Design for This Report |
| Table 141. Key Data Information from Secondary Sources |
| Table 142. Key Data Information from Primary Sources |
| List of Figures |
| Figure 1. Picture of Nuclear Medicine & Radiopharmaceuticals |
| Figure 2. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type: 2020 VS 2026 |
| Figure 3. Diagnostic Radioisotopes Product Picture |
| Figure 4. Therapeutic Radioisotopes Product Picture |
| Figure 5. Global Nuclear Medicine & Radiopharmaceuticals Consumption Market Share by Application: 2020 VS 2026 |
| Figure 6. Oncology |
| Figure 7. Cardiology |
| Figure 8. Other |
| Figure 9. Global Nuclear Medicine & Radiopharmaceuticals Market Size 2015-2026 (US$ Million) |
| Figure 10. Global Nuclear Medicine & Radiopharmaceuticals Sales Capacity (K Dose) (2015-2026) |
| Figure 11. Global Nuclear Medicine & Radiopharmaceuticals Market Size Market Share by Region: 2020 Versus 2026 |
| Figure 12. Nuclear Medicine & Radiopharmaceuticals Sales Share by Manufacturers in 2020 |
| Figure 13. Global Nuclear Medicine & Radiopharmaceuticals Revenue Share by Manufacturers in 2019 |
| Figure 14. The Global 5 and 10 Largest Players: Market Share by Nuclear Medicine & Radiopharmaceuticals Revenue in 2019 |
| Figure 15. Nuclear Medicine & Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 |
| Figure 16. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2015-2020) |
| Figure 17. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region in 2019 |
| Figure 18. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2015-2020) |
| Figure 19. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region in 2019 |
| Figure 20. North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country in 2019 |
| Figure 21. North America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country in 2019 |
| Figure 22. U.S. Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose) |
| Figure 23. U.S. Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 24. Canada Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose) |
| Figure 25. Canada Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 26. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country in 2019 |
| Figure 27. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country in 2019 |
| Figure 28. Germany Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose) |
| Figure 29. Germany Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 30. France Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose) |
| Figure 31. France Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 32. U.K. Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose) |
| Figure 33. U.K. Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 34. Italy Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose) |
| Figure 35. Italy Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 36. Russia Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose) |
| Figure 37. Russia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 38. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region in 2019 |
| Figure 39. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region in 2019 |
| Figure 40. China Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose) |
| Figure 41. China Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 42. Japan Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose) |
| Figure 43. Japan Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 44. South Korea Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose) |
| Figure 45. South Korea Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 46. India Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose) |
| Figure 47. India Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 48. Australia Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose) |
| Figure 49. Australia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 50. Taiwan, China Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose) |
| Figure 51. Taiwan, China Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 52. Indonesia Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose) |
| Figure 53. Indonesia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 54. Thailand Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose) |
| Figure 55. Thailand Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 56. Malaysia Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose) |
| Figure 57. Malaysia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 58. Philippines Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose) |
| Figure 59. Philippines Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 60. Vietnam Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose) |
| Figure 61. Vietnam Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 62. Latin America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country in 2019 |
| Figure 63. Latin America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country in 2019 |
| Figure 64. Mexico Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose) |
| Figure 65. Mexico Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 66. Brazil Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose) |
| Figure 67. Brazil Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 68. Argentina Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose) |
| Figure 69. Argentina Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 70. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country in 2019 |
| Figure 71. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country in 2019 |
| Figure 72. Turkey Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose) |
| 國際原子力醫學＆放射性醫薬品市場調査および動向分析レポート2020-2026 |
| Figure 73. Turkey Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 74. Saudi Arabia Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose) |
| Figure 75. Saudi Arabia Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 76. U.A.E Nuclear Medicine & Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose) |
| Figure 77. U.A.E Nuclear Medicine & Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million) |
| Figure 78. Sales Market Share of Nuclear Medicine & Radiopharmaceuticals by Type (2015-2020) |
| Figure 79. Sales Market Share of Nuclear Medicine & Radiopharmaceuticals by Type in 2019 |
| Figure 80. Revenue Share of Nuclear Medicine & Radiopharmaceuticals by Type (2015-2020) |
| Figure 81. Revenue Market Share of Nuclear Medicine & Radiopharmaceuticals by Type in 2019 |
| Figure 82. Global Nuclear Medicine & Radiopharmaceuticals Sales Growth by Type (2015-2020) (K Dose) |
| Figure 83. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2015-2020) |
| Figure 84. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application in 2019 |
| Figure 85. Global Revenue Share of Nuclear Medicine & Radiopharmaceuticals by Application (2015-2020) |
| Figure 86. Global Revenue Share of Nuclear Medicine & Radiopharmaceuticals by Application in 2020 |
| Figure 87. Company 1 Total Revenue (US$ Million): 2019 Compared with 2018 |
| Figure 88. Company 2 Total Revenue (US$ Million): 2019 Compared with 2018 |
| Figure 89. Company 3 Total Revenue (US$ Million): 2019 Compared with 2018 |
| Figure 90. Company 4 Total Revenue (US$ Million): 2019 Compared with 2018 |
| Figure 91. Company 5 Total Revenue (US$ Million): 2019 Compared with 2018 |
| Figure 92. Company 6 Total Revenue (US$ Million): 2019 Compared with 2018 |
| Figure 93. Company 7 Total Revenue (US$ Million): 2019 Compared with 2018 |
| Figure 94. Company 8 Total Revenue (US$ Million): 2019 Compared with 2018 |
| Figure 95. Company 9 Total Revenue (US$ Million): 2019 Compared with 2018 |
| Figure 96. Company 10 Total Revenue (US$ Million): 2019 Compared with 2018 |
| Figure 97. Company 11 Total Revenue (US$ Million): 2019 Compared with 2018 |
| Figure 98. Company 12 Total Revenue (US$ Million): 2019 Compared with 2018 |
| Figure 99. Company 13 Total Revenue (US$ Million): 2019 Compared with 2018 |
| Figure 100. Company 14 Total Revenue (US$ Million): 2019 Compared with 2018 |
| Figure 101. Company 15 Total Revenue (US$ Million): 2019 Compared with 2018 |
| Figure 102. Price Trend of Key Raw Materials |
| Figure 103. Manufacturing Cost Structure of Nuclear Medicine & Radiopharmaceuticals |
| Figure 104. Manufacturing Process Analysis of Nuclear Medicine & Radiopharmaceuticals |
| Figure 105. Nuclear Medicine & Radiopharmaceuticals Industrial Chain Analysis |
| Figure 106. Channels of Distribution |
| Figure 107. Distributors Profiles |
| Figure 108. Porter's Five Forces Analysis |
| Figure 109. North America Nuclear Medicine & Radiopharmaceuticals Sales (K Dose) and Growth Rate Forecast (2021-2026) |
| Figure 110. North America Nuclear Medicine & Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026) |
| Figure 111. Europe Nuclear Medicine & Radiopharmaceuticals Sales (K Dose) and Growth Rate Forecast (2021-2026) |
| Figure 112. Europe Nuclear Medicine & Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026) |
| Figure 113. Latin America Nuclear Medicine & Radiopharmaceuticals Sales (K Dose) and Growth Rate Forecast (2021-2026) |
| Figure 114. Latin America Nuclear Medicine & Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026) |
| Figure 115. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales (K Dose) and Growth Rate Forecast (2021-2026) |
| Figure 116. Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026) |
| Figure 117. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales (K Dose) and Growth Rate Forecast (2021-2026) |
| Figure 118. Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026) |
| Figure 119. Bottom-up and Top-down Approaches for This Report |
| Figure 120. Data Triangulation |
| Figure 121. Key Executives Interviewed |
略……
如需購買《Global Nuclear Medicine & Radiopharmaceuticals Market Research and Trends Analysis Report 2020-2026》，編號：2728311
請您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn 【網上訂購】 ┊ 下載《訂購協議》 ┊ 了解“訂購流程”
請您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn 【網上訂購】 ┊ 下載《訂購協議》 ┊ 了解“訂購流程”
京公網安備 11010802027365號